Unlocking the Potential of COL11A2P1: A Potential Drug Target and Biomarker

Target Name: COL11A2P1

NCBI ID: G394214

COL11A2P1

Other Name(s): Collagen, type XI, alpha 2 pseudogene 1 | collagen type XI alpha 2 pseudogene 1 | cD0826Q1.1 | COL11A2P

Unlocking the Potential of COL11A2P1: A Potential Drug Target and Biomarker

Introduction

Collagen is a protein that plays a crucial role in the structure and integrity of tissues, including skin, bones, and connective tissues. It is composed of multiple is types, each with distinct amino acid sequences. type XI collagen, also known as alpha 2 pseudogene 1 (COL11A2P1), is one of the most abundant types of collagen, making it an attractive target for drug development due to its various physiological functions and its potential to influence diseases such as cancer, autoimmune disorders, and skin diseases.

Objectives

This article aims to provide an overview of COL11A2P1, including its structure, function, and potential as a drug target. The article will discuss the current state of research on COL11A2P1 and highlight its potential as a drug target, as well as its potential as a biomarker for various diseases.

Structure and Function

COL11A2P1 is a type XI collagen that is characterized by its amino acid sequence, which consists of 116 amino acids. It has a unique feature, known as an alpha-helix, which is a type of secondary structure that is composed of a series of beta -helices that twist around a central alpha-helical axis. This alpha-helical structure gives COL11A2P1 its unique shape and stability.

In addition to its unique alpha-helical structure, COL11A2P1 also has a number of unique features that give it distinct properties. For example, it has a higher propensity to generate an alpha-helix than other types of collagen, such as type II and III . It also has a higher affinity for certain forms of UV radiation, which can lead to an increased risk of skin damage.

Potential as a Drug Target

The unique structure and function of COL11A2P1 make it an attractive target for drug development. Its alpha-helical structure and higher propensity to generate alpha-helices make it vulnerable to small molecules that can disrupt its proper function. Additionally, its unique properties, such as Its higher affinity for certain forms of UV radiation, provides insight into its potential to interact with the immune system.

COL11A2P1 has been shown to play a role in a number of diseases, including cancer, autoimmune disorders, and skin diseases. For example, studies have shown that high expression of COL11A2P1 is associated with an increased risk of skin cancer, including basal cell carcinoma( SKC) and squamous cell carcinoma (SCC). Additionally, high expression of COL11A2P1 has been linked to the development of autoimmune disorders, such as rheumatoid arthritis (RA) and lupus.

Potential as a Biomarker

COL11A2P1 has also been shown to have potential as a biomarker for various diseases. For example, studies have shown that high expression of COL11A2P1 is associated with the development of skin diseases, including eczema and psoriasis. Additionally, high expression of COL11A2P1 has been linked to the development of cancer, including SKC and SCC.

Conclusion

In conclusion, COL11A2P1 is a unique protein that has a number of distinct properties that make it an attractive target for drug development. Its alpha-helical structure and higher propensity to generate alpha-helices make it vulnerable to small molecules, while its unique properties, such as its higher affinity for certain forms of UV radiation, provide insight into its potential to interact with the immune system. Additionally, its association with diseases such as cancer, autoimmune disorders, and skin diseases makes it a promising biomarker for these conditions. Further research is needed to fully understand the potential of COL11A2P1 as a drug target and biomarker.

Protein Name: Collagen Type XI Alpha 2 Pseudogene 1

The "COL11A2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COL11A2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets